,2 AD is characterized biologically by amyloid plaques and tau deposition in the brain, while clinical syndromic diagnoses, such as specific forms of progressive memory loss, have evolved with the development of better AD diagnostic tests and biomarkers.3 This evidence concerns the gene MAPT and Alzheimer disease.